Medical Journals Credibility Questioned

April 13, 2009

Fake data published in medical journals are now being released. Here are some

that have been caught in a web of deceit.

The downward tailspin gathered force at the turn of the year, when it was

revealed that two studies detailing South Korean researcher Hwang Woo-suk's

breakthroughs with stem cell cloning were actually fabricated. The fraudulent

findings had been published in two different papers in the journal Science.

That was preceded by the revelation in December that Merck employees had

withheld critical data about heart attacks in a landmark Vioxx trial, published

in the New England Journal of Medicine in November 2000.

And, most recently, a paper that appeared last October in The Lancet showing

that non-steroidal anti-inflammatory drugs (NSAIDs) reduced the risk of oral

cancer has turned out to be completely false. The database of 908 study

participants itself was fabricated, with 250 of the people sharing the same

birth date. The author of that study, Dr. Jon Sudbo of the Norwegian Radium

Hospital in Oslo, Norway, has now also confessed to faking data for mouth cancer

studies published in the New England Journal of Medicine (April 2004) and the

Journal of Clinical Oncology (March 2005).

______________________________________

Thursday, March 12, 2009.

NaturalNews) The culture of deceit and fraud that permeates conventional

medicine became even more apparent today with the announcement that

Richman, the former vice president of a pharmaceutical company named Biopure,

faked his own cancer and even impersonated a doctor in order to convince a

federal judge that he was dying from colon cancer.

This bizarre deceit was an effort by Richman to squirm out of an SEC lawsuit

that accused Richman of misleading investors. According to the Associated Press,

Richman misled investors about the potential for FDA approval of a blood

replacement product called Hemopure, which is made from cow's blood. By faking

his own cancer and forging a doctor's note, Richman was able to get a

postponement of judgment in the SEC lawsuit, which effectively ended the legal

action he would have otherwise faced.

It all makes you wonder just how low the integrity standards really are at drug

companies these days. If a highly-paid executive can fake his own cancer in

order to avoid a lawsuit brought against him because he lied to investors, what

other sorts of fabrications and deceits might be going on at these companies?

Who can you believe????

Lottie

Recommended Posts